You are here

glaucoma

Skye Nixes Eye Disease Drug After Phase II Failure, Focuses on Metabolic Program

BioSpace

Mon, 06/10/24 - 05:49 pm

Skye Bioscience

clinical trials

Bausch + Lomb’s Faces of Glaucoma brings clarity to silent thief of sight

Medical Marketing and Media

Mon, 01/22/24 - 10:08 pm

pharma marketing

Glaukos Wins FDA Nod for Glaucoma Treatment Implant

Medical Devices and Diagnostics Industry

Tue, 01/2/24 - 10:06 pm

ocular hypertension

MediPrint’s drug-releasing contact lens reduces intraocular pressure in glaucoma patients

Clinical Trials Arena

Mon, 06/12/23 - 09:50 am

MediPrint Opthalmics

drug-releasing contact lens

FDA approves Skye Bioscience’s IND for glaucoma therapy trial

Clinical Trials Arena

Wed, 12/21/22 - 11:20 am

Skye Bioscience

clinical trials

Omlonti Granted FDA Approval in Glaucoma and Ocular Hypertension

Xtalks

Mon, 10/10/22 - 10:54 am

UBE Corporation

ocular hypertension

Glaukos beats path to FDA after eye implant trials hit goals

Fierce Pharma

Tue, 09/13/22 - 10:46 am

travoprost intraocular implant

ocular hypertension

Aerie’s glaucoma drug journey ends in $770M sale to Alcon

BioPharma Dive

Tue, 08/23/22 - 10:40 am

Aerie Pharmaceuticals

Small cannabinoid biotech gets hit with cyberattack, clinical trial delays

Endpoints

Wed, 07/20/22 - 10:23 am

Skye Bioscience

clinical trials

Visus, with one drug chasing AbbVie, inks deals to grow pipeline

Fierce Biotech

Thu, 08/19/21 - 10:45 am

Visus Therapeutics

A decades-old glaucoma drug tossed aside by Pfizer gets a new life at a small biotech

Endpoints

Tue, 08/10/21 - 10:37 am

phospholine iodide

Fera Pharmaceuticals

FDA approves Allergan’s biodegradable glaucoma implant drug

PM Live

Fri, 03/6/20 - 11:46 pm

Ocular's sustained-release insert misses bull's-eye in phase 3 glaucoma trial

Fierce Biotech

Tue, 05/21/19 - 09:59 am

Ocular Therapeutix

clinical trials

Betaliq Launches in Tampa to Focus on Glaucoma

BioSpace

Tue, 04/30/19 - 05:25 pm

Glaukos touts 5-year study of glaucoma stents

Mass Device

Mon, 04/15/19 - 11:09 pm

FDA Clears Aerie’s Combo Glaucoma Drug, But Will it Sell?

Xconomy

Wed, 03/13/19 - 10:18 am

Glaukos Keeps Its Eye on the Prize at J.P. Morgan

Medical Devices and Diagnostics Industry

Thu, 01/10/19 - 12:19 am

Novartis says glaucoma stent setback will not derail Alcon spin-off

Yahoo/Reuters

Wed, 08/29/18 - 10:34 am

CyPass Micro-Stent

Astellas grabs a biotech toddler in $109M buyout deal for a glaucoma gene therapy program

Endpoints

Fri, 08/10/18 - 09:12 am

Researchers Discovery Way to Regenerate Neurons Damaged by Glaucoma

CP Wire

Tue, 07/31/18 - 09:58 am

Pages